NCT01464918

Brief Summary

This trial is to evaluate the safety and efficacy of using MASTER, a robotics enhanced endosurgical system to perform endoscopic submucosal dissection (ESD) of gastric/colon cancer in human.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
7

participants targeted

Target at below P25 for not_applicable gastric-cancer

Timeline
Completed

Started Nov 2011

Shorter than P25 for not_applicable gastric-cancer

Geographic Reach
3 countries

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 30, 2011

Completed
2 days until next milestone

Study Start

First participant enrolled

November 1, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 4, 2011

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

November 4, 2011

Status Verified

October 1, 2011

Enrollment Period

1.1 years

First QC Date

October 30, 2011

Last Update Submit

November 1, 2011

Conditions

Keywords

gastric cancercolon cancerendoscopic submucosal dissection

Outcome Measures

Primary Outcomes (1)

  • Total time taken to complete the ESD procedure

    The total time spent from docking of MASTER to end of submucosal dissection

    Participants will be followed for the duration of the operation, an expected average of 3 hours

Secondary Outcomes (2)

  • Measure of ease of performing the ESD procedure

    Participants will be followed for the duration of the operation, an expected average of 3 hours

  • Safety

    From start of operation of the ESD procedure, assessed up to 7 days after the procedure

Study Arms (1)

ESD using the MASTER device

EXPERIMENTAL

Endoscopic submucosal dissection of gastric/colon cancer using the device, MASTER

Device: Endoscopic submucosal dissection (ESD) using device, MASTER

Interventions

Performing endoscopic submucosal dissection (ESD)of the gastric/colon cancer using the device, MASTER

ESD using the MASTER device

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient diagnosed with early gastric or colon cancer, is deemed suitable to undergo endoscopic submucosal dissection and is able/willing to give informed consent.

You may not qualify if:

  • case is deemed not suitable for endoscopic submucosal dissection
  • is on warfarin or other blood thinning agents and those with bleeding disorders
  • has uncorrected coagulopathy or severe thrombocytopenia precluding biopsy
  • has serious co-morbidities such as heart disease, renal impairment and cancer
  • has recently underwent surgery or has a personal history of stomach/colon cancer or surgery
  • is unable/unwilling to give informed consent
  • is pregnant or breast-feeding women patients who cannot undergo gastroscopies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Prince of Wales Hospital

Shatin, Hong Kong, China

Location

Apollo Gleneagles Hospitals

Kolkata, 700054, India

Location

National University Hospital

Singapore, 119074, Singapore

Location

Related Publications (6)

  • Phee SJ, Sun Z, Wang Z, Wong JY, Ho KY. The future of transluminal surgery. Expert Rev Med Devices. 2011 Nov;8(6):669-71. doi: 10.1586/erd.11.54. No abstract available.

    PMID: 22029463BACKGROUND
  • Sun Z, Ang RY, Lim EW, Wang Z, Ho KY, Phee SJ. Enhancement of a master-slave robotic system for natural orifice transluminal endoscopic surgery. Ann Acad Med Singap. 2011 May;40(5):223-30.

    PMID: 21678013BACKGROUND
  • Ho KY, Phee SJ, Shabbir A, Low SC, Huynh VA, Kencana AP, Yang K, Lomanto D, So BY, Wong YY, Chung SC. Endoscopic submucosal dissection of gastric lesions by using a Master and Slave Transluminal Endoscopic Robot (MASTER). Gastrointest Endosc. 2010 Sep;72(3):593-9. doi: 10.1016/j.gie.2010.04.009. Epub 2010 Jun 19.

    PMID: 20646698BACKGROUND
  • Phee SJ, Low SC, Huynh VA, Kencana AP, Sun ZL, Yang K. Master and slave transluminal endoscopic robot (MASTER) for natural orifice transluminal endoscopic surgery (NOTES). Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:1192-5. doi: 10.1109/IEMBS.2009.5333413.

    PMID: 19963992BACKGROUND
  • Phee SJ, Low SC, Sun ZL, Ho KY, Huang WM, Thant ZM. Robotic system for no-scar gastrointestinal surgery. Int J Med Robot. 2008 Mar;4(1):15-22. doi: 10.1002/rcs.179.

    PMID: 18314917BACKGROUND
  • Phee SJ, Ho KY, Lomanto D, Low SC, Huynh VA, Kencana AP, Yang K, Sun ZL, Chung SC. Natural orifice transgastric endoscopic wedge hepatic resection in an experimental model using an intuitively controlled master and slave transluminal endoscopic robot (MASTER). Surg Endosc. 2010 Sep;24(9):2293-8. doi: 10.1007/s00464-010-0955-8. Epub 2010 Feb 23.

    PMID: 20177915BACKGROUND

MeSH Terms

Conditions

Stomach NeoplasmsColonic Neoplasms

Interventions

Endoscopic Mucosal Resection

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach DiseasesColorectal NeoplasmsIntestinal NeoplasmsColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Khek Yu Ho, MBBS; MD

    National University Hospital, Singapore

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Khek Yu Ho, MBBS; MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2011

First Posted

November 4, 2011

Study Start

November 1, 2011

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

November 4, 2011

Record last verified: 2011-10

Locations